Entity

Time filter

Source Type

Nishi-Tokyo-shi, Japan

Patent
Zeria Pharmaceutical Co. | Date: 2013-10-29

Provided is a method for selectively demethylating a 2-methoxy group. Specifically provided is a production method of a compound represented by formula (7) below through the following reactions.


Patent
Zeria Pharmaceutical Co. | Date: 2013-10-29

Provided is a method for selectively demethylating a 2-methoxy group. Specifically provided is a production method of a compound represented by formula (7) below through the following reactions.


Patent
Zeria Pharmaceutical Co. and Saitama University | Date: 2014-02-10

To provide a therapeutic agent for gastrointestinal disorder such as diabetic gastroparesis. A postprandial gastrokinetic agent containing (A) ghrelin or a ghrelin agonist and (B) motilin or a motilin agonist as active ingredients, in which both the ingredients (A) and (B) are administered so as to act on the stomach after food intake.


Patent
Zeria Pharmaceutical Co. | Date: 2010-02-18

To provide a pharmaceutical agent or an antitumor agent useful for the treatment and/or prevention of gastrointestinal cancer, leukemia, pituitary tumor, small cell lung cancer, thyroid cancer, and neuroastrocytoma. The antitumor agent containing, as an active ingredient, a 1,5-benzodiazepine derivative represented by the following formula (1): (wherein R


Patent
Zeria Pharmaceutical Co. | Date: 2013-10-29

Provided is a method for selectively demethylating a 2-methoxy group. Specifically provided is a production method of a compound represented by formula (7) below through the following reactions.

Discover hidden collaborations